We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Diagnostic Tool Could Deliver Results in Two Minutes Using Fingertip Sample

By LabMedica International staff writers
Posted on 21 Oct 2022

Biofluids such as synovial fluid, blood plasma, and saliva contain proteins that are an important biomarker for the diagnosis of several health conditions. More...

Now, a specially designed platform has been programmed to detect the concentration of these proteins to assist in diagnosis and monitoring disease progression. The research proposes that hospital waiting times could be drastically cut and the option for self-screening and self-monitoring is now possible with the potential for at-home diagnostic kits in the future.

Scientists at Swansea University (Swansea, UK) developing a platform that would use artificial intelligence (AI) to speed up the process of detecting biomarkers in biofluids have shown that the concept could work. It would mean faster test results for health conditions such as cardiovascular disorders, joint quality, and Alzheimer’s disease. The new diagnostic tool could revolutionize the healthcare sector due to the application of a form of AI – machine learning (ML). The implementation of ML has meant it is possible, for the first time, for results to be delivered within minutes.

“The key innovation is the fact of providing a result within two minutes, which is a leap forward compared to standard testing that can take several hours,” said Dr. Francesco Del Giudice, project lead. "What this means for the future is that our proof-of-concept study can be further developed in a tool to help clinicians making decisions on clinical data obtained quickly. We also foresee to develop this further for an at-home-point-of-care self-screening diagnostic platform.”

“The ability of artificial intelligence to drive down the time required to complete various tasks has been demonstrated across a number of disciplines,” added Dr. Claire Barnes, co-author on the work. “The advantage of speed offered by the implementation of machine learning allowed us to adjust almost in real-time the experimental parameters to fulfill the requirements of the theoretical model associated with this work.”

Related Links:
Swansea University 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Slide Scanner System
NanoZoomer S540MD
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.